We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+308.35%
AUM
$6.2B
AUM Growth
+$96.9M
Cap. Flow
-$13.6M
Cap. Flow %
-0.22%
Top 10 Hldgs %
36.21%
Holding
102
New
2
Increased
29
Reduced
44
Closed
1

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$73.2M
2
MSFT icon
Microsoft
MSFT
+$71.3M
3
OTEX icon
Open Text
OTEX
+$54.8M
4
ADBE icon
Adobe
ADBE
+$43.2M
5
CNI icon
Canadian National Railway
CNI
+$28.7M

Top Sells

Rank Stock Value
1
SU icon
Suncor Energy
SU
+$76.9M
2
INTC icon
Intel
INTC
+$44.2M
3
B
Barrick Mining
B
+$32.5M
4
CM icon
Canadian Imperial Bank of Commerce
CM
+$23.6M
5
TD icon
Toronto Dominion Bank
TD
+$21.6M

Sector Composition

Rank Sector Weight
1 Financials 30%
2 Communication Services 18.69%
3 Materials 10.86%
4 Technology 9.79%
5 Healthcare 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCX icon
76
Freeport-McMoran
FCX
$97.5B
$566K 0.01%
9,625
– –
ALB icon
77
Albemarle
ALB
$15.5B
$444K 0.01%
2,475
– –
FTS icon
78
Fortis
FTS
$28.7B
$439K 0.01%
7,900
– –
EMA
79
Emera Inc
EMA
$15.6B
$438K 0.01%
8,485
– –
PVLA
80
Palvella Therapeutics
PVLA
$2.27B
$436K 0.01%
3,500
– –
ERO icon
81
Ero Copper
ERO
$3.58B
$390K 0.01%
14,700
– –
NAMS icon
82
NewAmsterdam Pharma
NAMS
$3.34B
$377K 0.01%
11,775
– –
ELVN icon
83
Enliven Therapeutics
ELVN
$4.43B
$376K 0.01%
+9,600
New +$266K
NXPI icon
84
NXP Semiconductors
NXPI
$60.4B
$349K 0.01%
1,775
– –
GOOGL icon
85
Alphabet (Google) Class A
GOOGL
$4.33T
$314K 0.01%
1,092
– –
MGTX icon
86
MeiraGTx Holdings
MGTX
$1.21B
$277K ﹤0.01%
32,000
– –
AMRZ
87
Amrize Ltd
AMRZ
$25.8B
$268K ﹤0.01%
4,941
– –
CABA icon
88
Cabaletta Bio
CABA
$455M
$243K ﹤0.01%
90,475
– –
BCAX
89
Bicara Therapeutics
BCAX
$1.84B
$222K ﹤0.01%
11,175
– –
KMB icon
90
Kimberly-Clark
KMB
$36.5B
$216K ﹤0.01%
+2,240
New +$229K
ORCL icon
91
Oracle
ORCL
$423B
$209K ﹤0.01%
1,420
– –
SPRY icon
92
ARS Pharmaceuticals
SPRY
$612M
$198K ﹤0.01%
24,700
– –
AURA icon
93
Aura Biosciences
AURA
$826M
$189K ﹤0.01%
28,300
– –
TENX icon
94
Tenax Therapeutics
TENX
$503M
$170K ﹤0.01%
10,650
– –
AQST icon
95
Aquestive Therapeutics
AQST
$494M
$147K ﹤0.01%
35,325
– –
TCRX icon
96
TScan Therapeutics
TCRX
$52M
$96.8K ﹤0.01%
95,875
– –
REPL icon
97
Replimune Group
REPL
$1.01B
$82.6K ﹤0.01%
10,800
– –
ALDX icon
98
Aldeyra Therapeutics
ALDX
$93.5M
$29.2K ﹤0.01%
17,300
– –
PROK icon
99
ProKidney
PROK
$337M
$28.5K ﹤0.01%
15,900
– –
HUMA icon
100
Humacyte
HUMA
$194M
$27.9K ﹤0.01%
45,950
– –
1 2 3
4
5

Similar funds

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.27B AUM 14.78% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Letko, Brosseau & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Letko, Brosseau & Associates held 102 positions worth $6.2B, up 1.6% from $6.11B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 2.9%. Letko, Brosseau & Associates opened 2 new positions and exited 1, leaving the 102-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 34% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q1 2026 buy was Enliven Therapeutics: 9,600 shares worth $376K.
  • Letko, Brosseau & Associates added most to Salesforce in Q1 2026, an estimated $73.2M increase.
  • Letko, Brosseau & Associates's biggest Q1 2026 reduction was Suncor Energy, cutting an estimated $76.9M.
  • Letko, Brosseau & Associates fully exited Shell in Q1 2026, selling an estimated $668K.
  • Letko, Brosseau & Associates's ten largest holdings make up 36% of its $6.2B portfolio in Q1 2026.
  • Letko, Brosseau & Associates opened 2 new positions and closed 1 in Q1 2026.
  • Letko, Brosseau & Associates's portfolio value rose 1.6% quarter-over-quarter to $6.2B.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.